West Pharmaceutical
669 hedge funds and large institutions have $28.4B invested in West Pharmaceutical in 2021 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 240 increasing their positions, 240 reducing their positions, and 52 closing their positions.
77% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 52
15% more capital invested
Capital invested by funds: $24.8B → $28.4B (+$3.69B)
5% more funds holding
Funds holding: 639 → 669 (+30)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0% more repeat investments, than reductions
Existing positions increased: 240 | Existing positions reduced: 240
2.89% less ownership
Funds ownership: 94.01% → 91.11% (-2.9%)
33% less call options, than puts
Call options by funds: $55.9M | Put options by funds: $83.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$72.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$65.1M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$64.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$167M |
| 2 |
Goldman Sachs
New York
|
-$135M |
| 3 |
UIM
USS Investment Management
London,
United Kingdom
|
-$128M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$105M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
-$100M |
WST Hedge Fund Activity: Q3 2021 in Review
669 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2021, worth a combined $28.4B — up 15% from $24.8B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new WST positions and 52 closed out — a net gain of 40 holders — while 240 added to existing stakes and 240 trimmed.
The largest buyer was Brown Advisory, adding an estimated $72.6M. The largest seller was Franklin Resources, cutting an estimated $167M.
- 669 institutional investors held West Pharmaceutical (WST) as of Q3 2021, up from 639 in Q2 2021.
- Funds reported $28.4B of West Pharmaceutical stock for Q3 2021, up 15% quarter-over-quarter.
- 92 funds opened new West Pharmaceutical positions in Q3 2021 and 52 closed out, a net change of +40 holders.
- The largest West Pharmaceutical buyer in Q3 2021 was Brown Advisory, an estimated $72.6M added.
- The largest West Pharmaceutical seller in Q3 2021 was Franklin Resources, an estimated $167M sold.
Based on aggregated 13F filings for Q3 2021.